EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

EFFICACY AND SAFETY OF ELICA-MTM CREAM (MOMETASONE FUROATE 0.1% W/W AND MICONAZOLE NITRATE 2% W/W) IN NAPKIN DERMATITIS OR DERMATITIS CAUSED BY INFECTION WITH CERTAIN FUNGI AND BACTERIA IN CHILDREN ZERO TO THREE YEARS OF AGE AN OPEN-LABEL, PHASE IV, MULTI

Eman AlMukhadeb* and Hend AlOtaibi

ABSTRACT

Background: Napkin dermatitis is a skin condition that affects the area under a baby's diaper. It is a very common dermatological disease in infants and children, mainly caused by excess moisture of the skin, or prolonged contact with urine and feces. Objective: Our study aimed to assess the efficacy and safety of Elica-MTM cream in children with napkin dermatitis with inflamed skin conditions of eczema or dermatitis caused by fungal and bacterial infections. Methods: This was an open-label, single-arm, phase IV study to evaluate the safety and efficacy of Elica-MTM cream in 69 children with napkin dermatitis with inflamed skin conditions of eczema or dermatitis caused by infection with certain fungi and bacteria. We conducted our study at two centers in the Kingdom of Saudi Arabia. All enrolled subjects were treated for 14 days and followed up for efficacy and safety assessments. Results: Efficacy evaluation showed that around 90% of patients had more than 50% reduction in the signs of erythema and pruritus. Meanwhile, evaluation of severity showed that at the baseline visit, the grades were 29%, 66.7% and 4.3% for mild, moderate, and severe, respectively. Finally, only two patients experienced moderate adverse events; not serious and were found to be unrelated to the study medication. Conclusion: The evaluation of the efficacy of Elica-MTM cream showed a substantial reduction in the signs and symptoms of erythema and pruritus. Additionally, the two moderate, adverse events reported indicate the high safety feature of Elica-MTM cream.

Keywords: Elica-MTM Cream, Napkin Dermatitis, Dermatitis, Eczema, Mometasone Furoate, Miconazole Nitrate.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 September 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: SEPTEMBER ISSUE PUBLISHED

    SEPTEMBER Issue has been successfully launched on 1 September 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )